CD19 and systemic lupus erythematosus: Among the four ASC populations, the most pronounced expansions were observed for CD19− Pop 4/5 between active SLE and vax-HC, although significant differences were also detected for CD19+ Pop2/3 between these two groups (Figs. 1e, 2).